Skip to main content
SpringerLink
Log in

CASE REPORT: Reflux Laryngitis in a Patient with Zollinger Ellison Syndrome and the Role of Epidermal Growth Factor

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pisegna JR: The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach. Curr Gastroenterol Rep 1:511-517, 1999

    Google Scholar 

  2. McGuigan J: Zollinger-Ellison syndrome and other hypersecretory states. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 6th ed. New York, W. B. Saunders, 1998, pp 679-693

    Google Scholar 

  3. Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT: Zollinger-Ellison syndrome clinical presentation in 261 patients. Medicine 79(6):379-411, 2000

    Google Scholar 

  4. Agha FP: Esophageal involvement in Zollinger-Ellison syndrome. Am J Roentgenol 144(4):721-725, 1985 (abstract)

    Google Scholar 

  5. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen RT, Maton PN: Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 99(2):341-346, 1990

    Google Scholar 

  6. Jensen RT: Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 243(6):477-488, 1998

    Google Scholar 

  7. Hirschowitz B: Zollinger-Ellison syndrome: Pathogenesis, diagnosis and management. Am J Gastroenterol 92(Suppl 4):44s-50s, 1997

    Google Scholar 

  8. Metz DC, Soffer E, Forsmark CE, Chey W, Boclerek W, Pisegna JR: Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. Am J Gastroenterol 6(2):157-162, 2003

    Google Scholar 

  9. Metz DC, Pisegna JR, Fishbegn VA et al. Currently used doses of omeprazole in Zollinger Ellison syndrome are too high. Gastroenterology. 1992 Nov; 103(5):1498-1508

    Google Scholar 

  10. Ormseth EJ, Wong KH: Reflux laryngitis: Pathophysiology, diagnosis, and management. Am J Gastroenterol 94(10):2812-2817, 1999

    Google Scholar 

  11. Shaker R, Milbrath M, Ren J, Tohill R, Hogan WJ, Li Q, Hofmann CL: Esophagophayngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 109:1575-1582, 1995

    Google Scholar 

  12. Wo JM, Grist WJ, Gussak G, Delgaudio JM, Waring JP: Empiric trial of high-dose omeprazole in patients with posterior laryngitis: A prospective study. Am J Gastroenterol 92(12):2160-2165, 1997

    Google Scholar 

  13. Jaspersen D, Weber R, Hammar CH, Draf W: Effect of omeprazole on the course of associated esophagitis and laryngitis. J Gastroenterol 31(6):765-767, 1996

    Google Scholar 

  14. Sarosiek J, Jensen RT, Maton PN, Peura DA, Harlow D, Feng T, McCallum RW, Pisegna JR: Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: Its protective potential. Am J Gastroenterol 95(5):1158-1165, 2000

    Google Scholar 

  15. Maccini DM, Veit B: Salivary epidermal growth factor in patients with and without acid peptic disease. Am J Gastroenterol 85(9):1102-1104, 1990

    Google Scholar 

  16. Sarosiek J, Feng T, McCallum RW: The interrelationship between salivary epidermal growth factor and the functional integrity of the esophageal mucosal barrier in the rat. Am J Med Sci 302(6):359-362, 1991

    Google Scholar 

  17. Sarosiek J, Bilski J, Murty VL, Slomiany A: Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coat. Biochem Biophys Res Commun 152(3):1421-1427, 1988

    Google Scholar 

  18. Lanas AI, Blas JM, Ortego J, Soria J, Sainz R: Adaption of esophageal mucosa to acid-and pepsin-induced damage: Role of nitric oxide and epidermal growth factor. Dig Dis Sci 42(5):1003-1012, 1997

    Google Scholar 

  19. Sarosiek J, Scheurich CJ, Marcinkiewicz M, McCallum RW: Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease. Gastroenterology 110(3):675-681, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The UCLA–San Fernando Valley Program, Olive View Medical Center–UCLA Medical Center, Department of Medicine, 14445 Olive View Drive, 2B-182, Sylmar, California, 91342-1438

    Benjamin M. Weinberg

  2. The CURE: VA/UCLA Digestive Disease Research Center, VA Greater Los Angeles Healthcare System and David Geffen School of Medicine at UCLA, Los Angeles, California, 90073, USA

    David S. Oh, Gordon V. Ohning & Joseph R. Pisegna

Authors
  1. Benjamin M. Weinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David S. Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordon V. Ohning
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph R. Pisegna
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weinberg, B.M., Oh, D.S., Ohning, G.V. et al. CASE REPORT: Reflux Laryngitis in a Patient with Zollinger Ellison Syndrome and the Role of Epidermal Growth Factor. Dig Dis Sci 49, 693–696 (2004). https://doi.org/10.1023/B:DDAS.0000026320.17006.14

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000026320.17006.14

Search

Navigation